SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

The cost of drug development: A systematic review · Study

ReviewThe cost of drug development: A systematic review

Steve Morgan2011

Review2011

The cost of drug development: A systematic review

Steve Morgan · Paul V. Grootendorst · Joel Lexchin · Devon L. Greyson

510 citations·0/0 files stored·Health Policy

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Health Systems, Economic Evaluations, Quality of Life Pharmaceutical industry and healthcare

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 510 citations exist upstream.

References

2003The price of innovation: new estimates of drug development costs 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge 2006Estimating The Cost Of New Drug Development: Is It Really $802 Million?1991Cost of innovation in the pharmaceutical industry 2007The cost of biopharmaceutical R&D: is biotech different?

Cited by

2016Key cost drivers of pharmaceutical clinical trials in the United States 2021How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment 2018Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study 2013Quality of life instruments for economic evaluations in health and social care for older people: A systematic review 2014How Drugs are Developed and Approved by the FDA: Current Process and Future Directions 2020Pricing of pharmaceuticals is becoming a major challenge for health systems 2021R&D Costs of New Medicines: A Landscape Analysis 2018Effects of price cap regulation on the pharmaceutical supply chain

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2021How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessmentreview · 5 shared references 2018Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation studyarticle · 5 shared references 2007Economics of New Oncology Drug Developmentarticle · 4 shared references 2012Commercializing biomedical research through securitization techniquesarticle · 4 shared references 2021R&D Costs of New Medicines: A Landscape Analysisarticle · 4 shared references 2011The productivity crisis in pharmaceutical R&Dreview · 3 shared references

Details

Year2011

Typereview

Published2011-01-22

VenueHealth Policy

ISSN-L0168-8510

Languageen

Citations510

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/j.healthpol.2010.12.002

openalex_workW1970577443

Links

Imported from OpenAlex (CC0) — nothing here is generated.